Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
McKinsey
Healthtrust
Daiichi Sankyo
Cipla
Express Scripts
Harvard Business School
Cerilliant
Johnson and Johnson

Generated: May 22, 2018

DrugPatentWatch Database Preview

TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Trimethoprim Sulfate And Polymyxin B Sulfate patents expire, and when can generic versions of Trimethoprim Sulfate And Polymyxin B Sulfate launch?

Trimethoprim Sulfate And Polymyxin B Sulfate is a drug marketed by Akorn Inc, Bausch And Lomb, and Sandoz Inc. and is included in three NDAs.

The generic ingredient in TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE is polymyxin b sulfate; trimethoprim sulfate. There are twelve drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the polymyxin b sulfate; trimethoprim sulfate profile page.

US Patents and Regulatory Information for TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE polymyxin b sulfate; trimethoprim sulfate SOLUTION/DROPS;OPHTHALMIC 065006-001 Dec 17, 1998 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bausch And Lomb TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE polymyxin b sulfate; trimethoprim sulfate SOLUTION/DROPS;OPHTHALMIC 064120-001 Feb 14, 1997 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz Inc TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE polymyxin b sulfate; trimethoprim sulfate SOLUTION/DROPS;OPHTHALMIC 064211-001 Apr 13, 1998 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Argus Health
Baxter
Harvard Business School
Daiichi Sankyo
Healthtrust
Cerilliant
Moodys
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.